News

ON THIS PAGEHow Diet Can Impact HAEFoods That May Trigger an AttackFoods That May Help SymptomsWhat to Eat During an EpisodeIf you’ve been living with hereditary angioedema (HAE), you may have a good ...
Review compares patient-important outcomes and assesses evidence among 42 systemic treatments in patients in 93 studies.
Pharvaris is advancing deucrictibant, an oral bradykinin B2-receptor antagonist, in two late-stage trials. Read my analysis ...
HAE attacks can now be treated with a pill, Ekterly (sebetralstat), instead by injection or infusion. That could translate to faster symptom relief.
The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, according to a press release from CSL Behring. The approval was based on data ...
According to a large study published in the Journal of Allergy and Clinical Immunology involving over 1.6 million patients, ...
Ekterly becomes the first FDA-approved oral on-demand treatment for hereditary angioedema in patients aged 12 years and older.
Angioedema is a well-known side effect of treatment with an angiotensin-converting enzyme (ACE) inhibitor and one that we have been willing to accept in view of the incidence of the problem and ...
Background: Angioedema without major urticarial flares (hives) is poorly understood. Its causes are diverse, and little is known about its pathogenic mechanisms. We report on our 11 years of ...
If you have hereditary angioedema (HAE), getting an accurate diagnosis can be tricky. Because HAE is so rare, many doctors aren’t familiar with the disease. Also, your symptoms can mimic those ...
In the past, doctors commonly prescribed anabolic steroids to prevent hereditary angioedema (HAE) attacks. While these medicines are sometimes useful, they can cause serious side effects, such as ...
Patients with hereditary angioedema experienced fewer hospitalizations and ED and outpatient visits after beginning prophylactic treatment with berotralstat, according to a poster presented at a ...